Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the addition of ZD1839 Iressa™ to standard
treatment with Casodex® (bicalutamide) for locally advanced prostate cancer can detect a
difference in the rate of decrease of prostate specific antigen (PSA) levels.